JMT103
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for JMT103, covering 2018-06-08 to 2024-01-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic Acid [Phase 3]